Sangamo Therapeutics Inc SGMO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/23/24 EDT
0.6179quote price arrow down-0.0181 (-2.8459%)
Volume
3,149,122
52 week range
0.29 - 1.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.6179
  • 52 Week High1.67
  • 52 Week High Date07/18/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap128.22M
  • Shares Out207.51M
  • 10 Day Average Volume2.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change13.73

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.6179
  • 52 Week High1.67
  • 52 Week High Date07/18/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23
  • Market Cap128.22M
  • Shares Out207.51M
  • 10 Day Average Volume2.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change13.73

RATIOS/PROFITABILITY

  • EPS (TTM)-1.86
  • P/E (TTM)-0.33
  • Fwd P/E (NTM)-1.17
  • EBITDA (TTM)-212.492M
  • ROE (TTM)-167.24%
  • Revenue (TTM)18.756M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,749.06%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sangamo Therapeutics Inc

 

Profile

MORE
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to...
H. Stewart Parker
Independent Chairman of the Board
Alexander Macrae Ph.D.
President, Chief Executive Officer, Director
Prathyusha Duraibabu CPA
Chief Financial Officer, Senior Vice President
Address
501 Canal Blvd.
Richmond, CA
94084
United States

Top Peers

SYMBOLLASTCHG%CHG
PRQR
ProQR Therapeutics NV
1.89-0.05-2.58%
GRTS
Gritstone bio Inc
0.8223-0.0198-2.3513%
SYRS
Syros Pharmaceuticals Inc
5.15-0.21-3.92%
COYA
Coya Therapeutics Inc
8.15+0.04+0.49%
OMGA
Omega Therapeutics Inc
2.12-0.11-4.93%